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U sing antibodies that recognize either tyrosinase, tyrosinase-
related protein-l (TRP1), or tyrosinase-related protein-2 
(TRP2, DOPAchrorne tautomerase), the quantities of those 
melanogenic enzymes were analyzed in five melanoma cell 
lines that possess various degrees of melanin production. All 
cells except JB /MS-W increased melanin production four 
to 30 times after 4 d of melanocyte-stimulating hormone 
(MSH) treatment. Melanin production by JB/MS-W cells 
was always under background, with or without MSH treat-
ment. There was a positive correlation between quantities 
and synthetic rates of those melanogenic enzymes and their 
melanin formation or DOPAchrome tautomerase activities. 
The activity of a heat-resistant melanogenic inhibitory factor 
T yrosinase is encoded by the albino locus of the mouse, and has been well known as the key enzyme responsi-ble for the formation of melanin pigment in animals [1,2]. In a previous study we reported that the protein named tyrosinase-related protein-l (TRP1), which is 
encoded by the brown locus (alternatively referred to as the b-pro-
tein or gp 75) has both of the catalytic properties ascribed to tyrosin-
ase, that is , tyrosine hydroxylase and 3,4-dihydroxyphenylalanine 
oxidase activities [3]. Using specific antibodies prepared against the 
predicted sequences of tyrosinase and TRP1, we have isolated those 
proteins from murine ~elanoma cells and h~ve reported that both 
have the catalytic functIOns ascnbed to tyrosl11ase [4]. The specific 
activity of the albino locus-encoded product was considerably 
higher than that of the protein encoded by the brown locus, al-
though the latter protein was present in higher quantity in murine 
melanocytes than was the protein encoded by the albino locus. 
Recently it has become clear that melanin production is regulated by 
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was also analyzed. The results showed, surprisingly, that pig-
mented cells showed higher levels of melanogenic inhibitors 
activity. Tyrosinase activity was increased dramatically 
whereas the level of melanogenic inhibitor was remarkably 
decreased following MSH treatment. Interestingly, melano-
genic inhibitor derived from JB /MS-W cells suppressed not 
only tyrosinase but also DOPAchrome tautomerase, another 
enzyme functional in melanin production. These results 
clearly suggest that melanin production is regulated by a 
subtle balance between the activities of these enzymes and 
other factors such as the melanogenic inhibitor. ] Invest Der-
matoI100:126-131,1993 
a subtle balance between positive melanogenic factors such as tyro-
sinase and DOPAchrome tautomerase [5]. and negative factors such 
as melanogenic inhibitors [6]. We have also reported recently 
that another cloned tyrosinase-related gene, TRP2, encodes 
DOPAchrome tautomerase, which plays an important role in the 
conversion of DOPAchrome to 5,6-dihydroxyindole-2-carboxylic 
acid [2,7,8]. 
In a previous study, we reported that JB/MS-W cells produce a 
factor inhibitory to tyrosinase [6]. although the relationship be-
tween quantities of melanogenic proteins and the activity of the 
melanogenic inhibitor are still not clear. Melanocyte-stimulating 
hormone (MSH) is a physiologically relevant stimulator of melano-
genesis that can be used to modulate rates of pigment production 
and examine this question [9]. We have now investigated 1) the 
quantities and synthetic rates of tyrosinase, TRPl and TRP2, and 
the effects of MSH on those parameters; 2) the activities of the 
melanogenic inhibitor in murine melanoma cell lines that possess 
various degrees of melanin production; and 3) the effect of the mel-
anogenic inhibitory factor on DOPAchrome tautomerase activity. 
MATERIALS AND METHODS 
Cell Lines and Culture Techniques JB/MS murine melanoma 
subclones and B 16Fl ° melanoma cells were used. These cells have 
been routinely cultured in Dulbecco's modified Eagle's medium 
with 10% fetal bovine serum and antibiotics, and their origin and 
characteristics have been previously described [6,10,11]. To study 
the effect of alpha MSH, synthetic MSH was purchased from Funa-
koshi (Tokyo, Japan) . 6 X 105 cells were seeded in 75-cm2 flasks, 
and 24 h later the media were changed, and included MSH (at 
0022-202Xj93j$06.00 Copyright © 1993 by The Society for Investigative Dermatology, Inc. 
126 
VOL. 100, NO. 2 FEBRUARY 1993 
2 X 10-7 M) where noted. The media were changed daily there-
after. After 4 d treatment, the cells were harvested, counted, 
and solubilized with 1% Nonidet P40 (NP40) , and melanogenic 
activities determined, as detailed below. 
Antibodies Anti PEPI antibody, which recognizes the COOH 
terminus of the brown protei n (TRPl) , anti-PEP7 antibody, which 
recognizes the COOH terminus of the albino-protein (tyrosinase), 
and anti-PEP8 antibody, which recognizes the COOH terminus of 
the slaty protein (TRP2) were used; the specificity of these rabbit 
antibodies has been previously described [4,7] . Normal rabbit serum 
was used as control. 
Flow-Cytometric Analysis After being harvested with trypsin: 
ethylened iaminetetraacetic acid (EDTA), 2 X 106 cells were fi xed 
and permeabilized with 70% ethanol, then stained with 50 ILl of a 
1: 50 dilution of PEPl, anti-PEP7, or anti-PEP8 antibodies. After 
washing, the cells were stained with fluorescein iso-
thiocyanate-conjugated goat antirabbit antibody, and after further 
washing, the cells were analyzed with an Epics Profile Analyzer. 
Nonspecific and background staining was determined by omitting 
the first antibody. The details were previously described [12]. 
Melanogenic Activity Assays 
Melanogenic Enzymes: Melanogenic activities were measured by 4-
or 16-h radiometric assays using 14C-tyrosine for total melanin pro-
duction, and 3H-tyrosine for tyrosine hydroxylase activity. The de-
tails of these methods were previously described [10] . Briefly, after 
being harves ted with trypsin: EDTA, the cells were solubilized at a 
concentration of lOs cells per 30 ILl with 1 % NP-40 in 0.05 M Tris 
Hel, pH 7.2, for 60 min at 4°C and then centrifuged. The melano-
genic activities of the cell extracts were then measured. The tyro-
sinase assay measures the production of 3H-water as tyrosine is hy-
droxylated to 3,4-dihydroxyphenylalanine; this assay measures only 
the first enzymatic function of tyrosinase. The melanin formation 
assay measures the radioactive melanin formed as 14C-tyrosine is 
converted to the acid-insoluble melanin biopolymer; this assay mea-
sures the complete reaction sequence, and reflects the melanogenic 
activities of tyrosinase, TRPl, TRP2, and inhibitory factors. 
DO PAchrome tautomerase activity was measured by high-perform-
ance liquid chromatography as the disappearance of DOPAchrome 
substrate and the production of 5,6-dihydroxyindole-2-carboxylic 
acid, rather than 5,6-dihydroxyindole (DHI) [13]. DHI and 5,6-di-
hydroxyindole-2-carboxy lic acid were kindly provided by Drs. 
Anna Palumbo and Giuseppe Prota, Naples, Ita ly. 
MelanogeniC Inhibitor: To compare the activities of melanogenic 
inhibitors amongJB/ MS subclones and B16FIO cells, the inhibitor 
frac tions purified as detailed below were diluted 40 times with 
0.05 M Tris HCI buffer, pH 7.2, and 40 ILl was added to 0.5 ILg 
purified tyrosin.ase derived from B16FI0 melanoma, and the mela-
nin formation assay was performed. 
Metabolic Labeling and Radioimmunoprecipitation For 
metabolic labeling, cells were grown to semiconfluence and then 
pulsed for 1 h with 35S-methionine and chased for 60 min, as previ-
ously detailed [4]. After the labeling, the cell number was counted, 
and 4 X 106 cells were solubilized with 1 % NP40 in 10 mM Tris 
Hel, pH 7.2, and incubated with anti-PEPl, anti-PEP7, or anti-
PEP8 antibodies for 60 min at 37"C. They were then complexed 
with 100 ILl of 10% protein A - sepharose for 30 min, and the im-
mune complexes were washed five times with 1 % NP40 with 
10 mM Tris-HCl buffer. After being heated to 100°C in the pres-
ence of sodium dodecylsulfate and reducing agent, the labeled pro-
teins released from the immune complexes were counted. For nega-
tive controls, normal rabbit immunoglobulin G was used instead of 
the peptide-specific antibodies . 
Purification and Activity of Melanogenic Inhibitor JB/MS-
W melanoma cells were grown as subcutaneous tumors in nude 
mice, then disrupted in distilled water using a Polytron Sonicator 
(200 ml per 50 g tumor, wet weight). The pH of the cell extract was 
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adjusted to 5.3 with acetic acid and the sample was heated at 65 °C 
for 1 h. The heat-soluble proteins were recovered following centrif-
ugation at 40,000 X g for 10 min, and the supernatant was brought 
to neutral pH and used as a crude inhibitor fraction. For making 
low - molecular-weight inhibitor fraction, the crude fraction was 
passed through a YM2 1,000 molecular weight cutoff membrane 
(Amicon Corp., Lexington, MA). To further purify the inhibitor, 
the low - molecular-weight fraction was resolved by DEAE Sepha-
dex and Dowex 50WX-8 chromatograph y, methanol precipita-
tion, and chloroform extraction. The sample was then lyophilized 
in water twice, and resuspended in 0.1 M Tris HCl buffer, pH 7.2. 
This sample was used as the high ly purified inhibitory factor and 
was used to check the effect on purified tyrosinase and 00-
PAchrome tautomerase activi ties. The purification of the melano-
genic inhibitor was at least 12,000 times determined by protein 
concentratIOn. 
Gel Filtration Chromatography The 1 % NP40 cell extracts of 
JB/MS cells, which had been cultured with or without MSH, were 
passed through Sephadex G75 columns (55 by 0.9 cm) in 0.05 M 
Tris HCl, pH 7.2, buffer. The flow rate was 1 ml/min, and 2-ml 
fr~ctlons were collected. Ca libration of molecular weights was done 
With standard protems. To determine the elution position of tyro-
Sll1ase and melanogenic inhibitor, an aliquot of each fraction was 
added to a standard amount of purified tyrosinase or buffer and the 
14C-tyrosine assay was performed . To know the effect of heat treat-
ment, each fraction was preheated at 65 ° C for 1 h and then used for 
14C-tyrosine assay. 
Purification of Tyrosinase Purification of tyrosinase from pig-
mented B 16 melanoma cell s was performed as previously described 
[14]. 
RESULTS 
Melanogenic Activity and the Effects of MSH As we previ-
ously found [6], there were no significant differences in the prolifer-
ation rates of any of the cell lines elicited by MSH during the 4-d 
time course of these experiments. The original JB/MS melanoma 
cells were responsive to treatment with MSH, and after 4 d in-
creased their tyrosine hydroxylase activity about ninefo ld and their 
melanin formation approximately thirtyfold (Table I) . However, a 
long-term-passaged line of these ce ll s, termed JB/ MS-P, had a 
reduced basal level of melanogenic activity. In an earlier study [10] , 
we subcl?ned these heterogeneous populations and obtained an 
amelanotic cell 1ll1e termed JB/MS-W and a highly pigmented 
clone termed JB/ MS-B. JB/MS-W cells had levels of tyrosinase 
activity and m elanin formation actually under background and were 
not responsive to treatment with MSH. On the other hand, scveral 
pign:ented clones (e.g., JB/ MS-B) had basa l levels of melanogenic 
activities even higher than the originally derived parental line and 
were r~sponslve to MSH treatment. Interestingly, the basa l level of 
melanll1 formatIOn ofB 16F1 0 cells was higher than that of JB/MS 
cells, and th ey were also responsive to MSH treatment. There was a 
positive correlation between tyrosine hyd roxy lase activity and mela-
nin formation in JB/ MS subclones. 
As concerns DOPAchrome tautomerase, pigmented melanoma 
clones such asJB/MS,JB/MS-B, and B 16FI0 showed higher activi-
ties, and JB/ MS-P showed lower activity. Interestingly, the level of 
the DOPAchrome tautomerase activity on JB/ MS-W cells I ike mel-
anin formation was also at background level. MSH treatment in-
creased their DOPAchromc tautomerase activity sli gh tl y except 
JB/ MS-W cells. 
Flow-Cytometric Analysis and Radioimmunoprecipita-
tion The relative amounts of tyrosinase, TRPl, and TRP2 
present in these cell lines were examined with anti-PEP7, anti-
PEPl, and anti-PEP8 antibodies, respectively, using flow cytome-
try. An examination of tyrosinase content using the anti-tyrosinase 
antibody (anti-PEP7) showed that pigmented JB/MS-B cells 
showed strong fluorescence intensity (Fig 10). The amela notic JB/ 
MS-W cells showed a greatly reduced fluorescence intensity (Fig 
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Table I. Melanogenic Activity and the Effect of MSH on Cell Lines Used in This Study' 
Tyrosine Melanin DOPAchrome 
Hydroxylase Formation Tautomerase 
Cell Line Visible Pigment MSH (-) MSH (+) MSH (-) MSH(+) MSH (-) MSH(+) 
JB/MS ++ 137 ± 10 1169 ± 33 19 ± 5 529 ± 28 132 ± 17 142 ± 21 
JB/MS-P + 101 ± 9 946 ± 15 14 ± 3 401 ± 17 48 ± 12 56 ± 14 
jB/MS-W -6±5 -3±2 -2±2 -1 ±2 4±5 4±3 
JB/MS-B ++ 980 ± 26 1761±20 275 ± 14 1150±34 148 ± 24 162 ± 20 
B16FI0 ++ 725 ± 14 2851 ± 10 32 ± 7 315 ± 51 116 ± 14 136 ± 24 
• Melanoma cells were cultured, harvested, and solubilized as described in Materials alld Methods. The results represent the means of assays carried out in triplicate SO. 
Backgrounds of buffer controls have been subtracted from the data presented. The data are expressed as pmol/IOs cells/h. 
Ib), although it was significantly higher than the negati.ve control 
(Fig Ie) . Using similar techmques with the other cell. I.mes, there 
was a positive correlatIOn between melanogenic activIties and the 
expression of those melanogemc prote111s (summarized 111 Fig 2) . In 
all cell lines, the fluorescence 111tenslt!es of antl-tyrOSl11ase antibod-
ies were higher than the fluorescence intensities of antibodies recog-
nizing TRPI or TRP2. Treatment with MSH did not. change t!1e 
fluorescence intensities significantly m any of the celllmes, despite 
the dramatic effects it had on levels of enzyme activity. 
Radioimmunoprecipitation showed that there was also a positive 
correlation between the melanogenic activities and synthetic rates 
of tyrosinase, TRPI, and TRP2 by the JB/MS subclones and 
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Figure 1. Flow-cytometric analysis of tyrOSinase content. After culture 
without MSH, the cells noted were harvested, fixed WIth 70% ethanol, 
and stained with anti-PEP7 antibody as detailed in Materia ls and Methods . 
The vertical axis shows the relative cell number per channel; the horizolltal 
ax is shows the relative fluorescence intensity in logarithmic units. a, jB/ 
MS-B; b, JB/MS-W; c, negative control. 
B16FIO cells (Fig 3). Each cell line showed comparable synthetic 
rates of all three enzymes. MSH treatment had no significant effect 
on the synthesis of those enzymes in any of the cell lines. The 
amelanotic JB/MS-W cells also produced significant amounts of 
melanogenic enzymes, which is consistent with the flow-cytome-
tric results presented above. 
Inhibition of Melanogenesis The presence of the melanogenic 
inhibitor was also determined for each of these cell lines, before and 
after endogenous tyrosinase was removed by heat treatment. Each of 
the extracts significantly suppressed melanin formation by purified 
tyrosinase (Table II). Surprisingly the cell extracts of the pigmented 
cel l lines (JB/MS,JB/MS-B, and BI6FlO) showed higher levels of 
inhibition than did those of the less-pigmented (JB/MS-P) or ame-
lanotic (JB/MS-W) ce ll lines. The low-molecular-weight nature 
of the melanogenic inhibitor is evident because the bu lk of the 
inh ibitory activity passed through a 1000 molecular weight cutoff 
membrane. 
Purification of the inhibitor by gel filtration chromatography of 
extracts of the JB/MS cells showed elution of active melanogenic 
enzyme around 65 kD (as expected), whereas the melanogenic in-
hibitor eluted at lower molecular weight primari ly in peaks of 
25 kD and 8 kD (Fig 4a). After MSH treatment, JB/MS cells in-
creased their melanin production more than 70 times (from 15 + 2 
to 1053 + 20 pmol/IOs cells/h), and the active tyrosinase peak at 
65 kD increased approximately twentyfold. After MSH treatment 
of the cells, the concentration of the melanogen ic inhibitor was 
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Figure 2. Flow-cytometric analyses of tyrosinase, TRPl, and TRP2 con-
tents. After culture with (+) or without (-) MSH for 4 d, the cells were 
fixed, permeabilized, and stained with antibodies as detailed in Materia ls 
and Methods. The Ilertica i axes show the difference between mean fluores-
cence of specific histogram and the negative control. 
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Figure 3. Synthesis of tyrosinase, TRP1, and TRP2. The cells were grown 
in the absence (-) or presence (+) of MSH for 4 d, th.en labeled with 
35S-methionine, harvested, solubilized with NP-40, and lffimunopreapl-
tated with anti-PEPI, anti-PEP7, or anti-PEP8 antibodies as detailed in 
Materials alld Methods. The data are expressed as the specific radioincorpor-
ation minus background obtained with control immunoglobulin G. The 
data represent the means of assays carried out in triplicate (SO < 15%). 
significantly decreased, and the peaks around 25 kD and 8 kD al-
most completely disappeared (Fig 4a). . .. 
To examine the effect of heat treatment on these activItieS, each 
fraction resolved by gel filtration chromatography (in Fi~ 4A) was 
treated as 65 ° C for 1 h (Fig 4B); this treatment destroys virtually a.ll 
tyrosinase activity but has no significan.t effect on the melanogenic 
inhibitor. After heat treatment of fractIOns from untreat~d J.B(MS 
cells the activities of both melanogenic enzymes and 111hlbltO~ 
fact~rs were similar (compare - MSH in Fig 4a and b) . How~ver., I.n 
fractions derived fromJB/MS cells cultured with MSH, t.he 111hlbl-
tory activity completely disappeared and .those fr~ctlOns now 
showed a slight stimulation of melanogenic activIties (compa:e 
+ MSH in Fig 4A and B) . It is very clear that melanocytes grown I.n 
the presence of MSH have no detectable level of melanogenic 
inhibitor. . 
We then examined the effect of the highly purified melan?~e~l1C 
inhibitor on tyrosinase and DOPAchrome tautomerase act.lVlties. 
The inhibitory factor suppressed tyr~sin~ ?ydroxylase actlVlty and 
melanin formation even when the 111hlbitOry factor was greatly 
diluted (Fig 5). The inhibitor also sig~ificantly inhi~i~ed 
DOPAchrome tautomerase activity, although It was not as sensitive 
as tyrosinase at the higher dilutions. 
Control 
fB/MS 
JB/MS-P 
JB/MS-W 
JB/MS-B 
B16FIO 
Table II. Activity of Melanogenic Inhibitor 
on Melanin Formationa 
Crude Inhibitor 
Fraction 
86 ± 10% 
80 ± 14% 
60±9% 
88±7% 
86 ± 12% 
Low - Molecular-Weight 
Inhibitor Fraction 
16 ± 2 pmol/16 h 
73 ± 12% 
70 ± 16% 
42 ± 12% 
76 ± 14% 
72 ± 17% 
• The ceJllines noted were partially purified into the inhibitor fractions noted in 
the Materials alld Methods section. The data are expressed as percent suppressIOn of a 
standard aliquot of purified mammalian tyrosinase, and represent the means of 
assays carried out in triplicate ± SO. 
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Figure 4. Gel-filtration chromatography of ]B/MS cells. The cells were 
cultured with or without MSH, then solubilized and separated by chroma-
tography on Sephadex G75 . Aliquots of the fractions were then assayed 
with purified tyrosinase as detailed in Materials alld Methods. The results are 
presented as the average of percent inhibition of tyrosinase activity ob-
tained in triplicate assays of each fraction compared to controls containing 
only buffer. A) Standard inhibitor assay, B) standard inhibitor assay fol -
lowing heat treatment (65 °C for 1 h) . 
DISCUSSION 
We have already reported that not only tyrosinase but also TRPl 
possesses melanin-formation activity [3,4]. In those studies, the 
quantities ofTRP! produced in thecellswere typically equ~l . to or 
higher than tyrosl11ase. However, 111 tlllS study, the quantities of 
TRP1 detected by immunofluorescence were generally lower than 
tyrosinase in all the cell lines examined (Fig 2). In part, these differ-
ences might reflect various efficiencies or binding affinities of the 
epitopes to anti-PEPl and anti-PEP7 antibodies in villo . Therefore, 
although it may be ambiguous to compare the absolute amounts of 
those two proteins in cells using such immunologic analysis, it is 
possible to compare the relative amounts of either protein among 
the different cell lines. This study showed that there is a positive 
correlation between the quantity and synthetic rates of those en-
zymes and the melanin-formation activities in the various cell lines. 
These results clearly suggest that tyrosinase, TRP1, and TRP2 are 
coordinately regulated as members of a tyrosinase gene family, and 
that not only tyrosinase but also TRP1 and TRP2 play important 
roles in the regulation of melanin production. The report that trans-
fection of v-RAS oncogene to murine melanocytes suppressed tran-
scrirtion and translation not only of tyrosinase but also of TRPl 
[15 further supports the hypothesis that those enzymes are coordi-
nately regulated as a tyrosinase gene family. 
The levels of tyrosine hydroxylase activity and melanin forma-
tion activity of JB/MS-W cells were below background, whereas 
the level of DOPA chrome tautomeraseof]B/MS-W cells are at back-
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Figure 5. Effect of melanogenic inhibitor on tyrosinase and DOr A-
chrome tautomerase. B16FIO melanoma cells were grown in media in the 
absence or presence of MSH for 4 d, then solubilized, and tyrosinase and 
Dor Achrome tautomerase were immune-affinity purified, as detailed in 
[7]. These enzymes ~ere !hen as~ayed for melan?g~nic ~ctivities follow-
ing 1 h pre-incubation WIth purified melanogeruc mhibltors at the con-
centrations noted. Melanogeruc assays were performed as detailed in 
Materials and Methods, and results are shown in pmol/h/Ilg protein 
(mean ± SD, n = 3). 
ground level (Table I). However those cells possess about 25% of 
the amount and synthetic rate of melanogenic enzymes compared to 
pigmented melanoma cells such as JB/MS-B (Figs 2 and 3). Follow-
ing MSH trea~ment,JB/MS c~lls increased their tyrosine hydroxyl-
ase activity mnefold and their melanlll formation thlrtyfold, al-
though the total amounts of tyrosinase, TRPl, and TRP2 in those 
cells were almost the same. These findings agree with previous 
reports [12,16 - 18] on t.h~ post-translational effects of MSH in regu-
lating melanogemc activity. 
Because we have already reported that JB/MS-W cells produce a 
heat-stable melanogenic inhibitor [6], we studied the quantitative 
activities of that inhibitor in all cell lines (Table II). The results were 
surprising because the highly pigmented melanoma cells (such as 
JB/MS-B and BI6FI0) showed higher contents of the inllibitor 
than did the amelanotic JB/MS-W cells (Table II) . The reason for 
the positive correlation between melanin-formation activity and the 
presence of the inhibitor is unclear, but it is obvious that there is a 
dynamic equilibrium between levels of tyrOSlllase and the melano-
genic inhibitor that determines the rate of melanlll production. To 
further address this question, we measured the melanogenic activity 
of each fraction separated by gel filtration. After MSH treatment, 
the activity of melanogenic enzymes dramatically increased, 
whereas the activity of melanogenic inhibitors was remarkably de-
creased (Fig 4). The majority of the melanogenic inhibitor passes 
readily through a 1000 molecular weight cutoff membrane, yet the 
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distribution of the inhibitor in gel-filtration analysis is seen in many 
higher molecular weight fractions. This suggests a reversible associ-
ation between the inhibitor, either in a homo- or heteropolymer 
(perhaps with tyrosinase and/or DOPAchrome tautomerase). 
These results suggest that active and inactive types of tyrosinase, 
TRPl, and TRP2 exist in melanocytes and that inhibitors of those 
enzymes play an important role in the regulation of melanin produc-
tion, especially with respect to responses induced by MSH treat-
ment. Although an unstable melanogenic inhibitor has been re-
ported [19]' our results suggest that most of the inhibitory activity 
was heat resistant and that relatively higher amounts of inhibitor 
were necessary to modulate higher levels of tyrosinase to regulate 
melanogenesis. Interestingly, in gel filtration experiments ofMSH-
treated cellular extracts, some fractions still revealed the presence of 
inhibitors (Fig 4a) but after heat treatment, those same fractions 
showed stimulation of the melanogenic activity of tyrosinase. The 
reason for this phenomenon is still unclear but suggest the possibil-
ity that induction of differentiation results in shifting the produc-
tion of a melanogenic inhibitor to stimulator, thus eliciting the 
dramatic increases in melanin production without significant in-
creases in tyrosinase synthesis. Moreover, significant levels of alter-
native splicing of precursor mRNA for tyrosinase and TRP1 have 
been demonstrated [20 - 22] and alternative splicing has been shown 
to playa critical role in the regulation of structure and function of 
other proteins such as fibronectin [23] and various immune-system 
proteins [24,25]. Those reports suggest that such a mechanism 
might play a role in the regulation of tyrosinase and its related 
proteins in the determination to produce a functionally active en-
zyme. 
In summary, this study has shown that 1) there is a positive 
correlation between the quantities and synthetic rates of tyrosinase, 
TRPl, and DOPAchrome tautomerase (TRP2) and the visible pig-
mentation in all cell lines studied and that expression of these three 
proteins is coregulated; 2) MSH treatment showed no significant 
effect on the synthetic rates or total amounts of these melanogenic 
enzymes in JB/MS subclones or B16F10 cells; 3) surprisingly, pig-
mented melanoma cells such as JB/MS-B and B16FI0 showed 
higher activities of the heat-stable, low-molecular-weight melan-
ogenic inhibitor than did the amelanotic line; 4) the melano-
genic inhibitor suppressed not only tyrosinase activity but also 
DOPAchrome tautomerase activity; and 5) the effect of MSH treat-
ment may actually be to decrease the level of melanogenic inhibitor. 
To further address these questions, we are continuing to study the 
inhibitor to determine its structure, its mechanism of action itl vivo, 
and its relationship to the stimulator activity induced by MSH treat-
ment. 
We wish to thallk Mr. Yuji Shillloda, S.M.!. Bristol, KalJagawa,japall,jor Iris help 
with the flow-cytolll etric studies. 
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ANNOUNCEMENT 
The annual meeting of the Society for Pediatric Dermatology will be held July 28 - 31, 1993 at 
Snowmass, Colorado. The meeting will immediately follow the 42nd annual Symposium on 
the Biology of Skin. Those wishing further information please write to: 
SPD-Snowmass 
Department of Dermatology B-153 
University of Colorado School of Medicine 
4200 East Ninth Avenue 
Denver, Co lorado 80262 
